Pub. Date : 2010 Feb
PMID : 20001232
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The dual BCR-ABL/SRC family kinase inhibitor, dasatinib, has shown promising activity in the treatment of Ph+ ALL after imatinib failure and has recently been approved in this indication. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |